During the past decade, Oregon Oncology Specialists conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Oncology Specialists" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Astex Pharmaceuticals, Inc." with 1 trials sponsored, "Celcuity, Inc." with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "EQRx, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Oncology Specialists" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Oncology Specialists" are "Acute Myeloid Leukemia" (1 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Tumor" (1 trials) and "Chronic Myelocytic Leukemia" (1 trials). Many other conditions were trialed in "Oregon Oncology Specialists" in a lesser frequency.

Most popular intervention types in "Oregon Oncology Specialists" are "Drug" (8 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Niraparib" (2 trials), "ASTX030 (cedazuridine + azacitidine)" (1 trials), "Abiraterone acetate (AA)" (1 trials), "Acalabrutinib" (1 trials) and "Alpelisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Oncology Specialists" are 7 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Oregon Oncology Specialists". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Oregon Oncology Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Oncology Specialists, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".